[1] |
Sakai Y, Fukai R, Matsushita Y, et al. De novo truncating mutation of TRIM8 causes early-onset epileptic encephalopathy[J]. Ann Hum Genet, 2016, 80(4): 235-240.
doi: 10.1111/ahg.2016.80.issue-4
|
[2] |
Weng PL, Majmundar AJ, Khan K, et al. De novo TRIM8 variants impair its protein localization to nuclear bodies and cause developmental delay, epilepsy, and focal segmental glomerulosclerosis[J]. Am J Hum Genet, 2021, 108(2): 357-367.
doi: 10.1016/j.ajhg.2021.01.008
|
[3] |
Warren M, Takeda M, Partikian A, et al. Association of a de novo nonsense mutation of the TRIM8 gene with childhood-onset focal segmental glomerulosclerosis[J]. Pediatr Nephrol, 2020, 35(6): 1129-1132.
doi: 10.1007/s00467-020-04525-3
|
[4] |
McClatchey MA, du Toit ZD, Vaughan R, et al. Focal segmental glomerulosclerosis and mild intellectual disability in a patient with a novel de novo truncating TRIM8 mutation[J]. Eur J Med Genet, 2020, 63(9): 103972.
doi: 10.1016/j.ejmg.2020.103972
|
[5] |
Assoum M, Lines MA, Elpeleg O, et al. Further delineation of the clinical spectrum of de novo TRIM8 truncating mutations[J]. Am J Med Genet A, 2018, 176(11): 2470 -2478.
doi: 10.1002/ajmg.a.40357
pmid: 30244534
|
[6] |
Zhang Y, Zhang W, Zheng L, et al. The roles and targeting options of TRIM family proteins in tumor[J]. Front Pharmacol, 2022, 13: 999380.
doi: 10.3389/fphar.2022.999380
|
[7] |
Hatakeyama S. TRIM family proteins: roles in autophagy, immunity, and carcinogenesis[J]. Trends Biochem Sci, 2017, 42(4): 297-311.
doi: 10.1016/j.tibs.2017.01.002
|
[8] |
Marzano F, Guerrini L, Pesole G, et al. Emerging roles of TRIM8 in health and disease[J]. Cells, 2021, 10(3): 561.
doi: 10.3390/cells10030561
|
[9] |
Ye W, Hu MM, Lei CQ, et al. TRIM8 negatively regulates TLR3/4-mediated innate immune response by blocking TRIF-TBK1 interaction[J]. J Immunol, 2017, 199(5): 1856-1864.
doi: 10.4049/jimmunol.1601647
|
[10] |
Maarifi G, Smith N, Maillet S, et al. TRIM8 is required for virus-induced IFN response in human plasmacytoid dendritic cells[J]. Sci Adv, 2019, 5(11): eaax3511.
doi: 10.1126/sciadv.aax3511
|
[11] |
Schoch K, Meng L, Szelinger S, et al. A recurrent de novo variant in NACC1 causes a syndrome characterized by infantile epilepsy, cataracts, and profound developmental delay[J]. Am J Hum Genet, 2017, 100(2): 343-351.
doi: S0002-9297(16)30539-0
pmid: 28132692
|
[12] |
Chernin G, Vega-Warner V, Schoeb DS, et al. Genotype/phenotype correlation in nephrotic syndrome caused by WT1 mutations[J]. Clin J Am Soc Nephrol, 2010, 5(9): 1655-1662.
doi: 10.2215/CJN.09351209
|